Kengo Miyoshi
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kengo Miyoshi.
Tetrahedron Letters | 1995
Akira Otaka; Kengo Miyoshi; Terrence R. Burke; Peter P. Roller; Hideki Kubota; Hirokazu Tamamura; Nobutaka Fujii
Abstract Synthesis of N-Boc-L-2-amino-4-(diethylphosphono)-4,4-difluorobutanoic acid is reported. This analogue was utilized for the solid-phase synthesis of a peptide containing a nonhydrolyzable phosphoserine mimetic.
Journal of The Chemical Society-perkin Transactions 1 | 1996
Hirokazu Tamamura; Tsunehito Ishihara; Akira Otaka; Takaki Koide; Kengo Miyoshi; Toshiro Ibuka; Nobutaka Fujii
Cystine-containing peptides are obtained in a one-pot manner by treatment of protected peptidyl resins with trimethylsilyl chloride (TMSCl)–dimethyl sulfoxide (DMSO)–trifluoroacetic acid (TFA). The TMSCl–DMSO–TFA system simultaneously cleaves peptides from the resins, with deprotection of all side chain protecting groups and disulfide bond formation.
Journal of The Chemical Society, Chemical Communications | 1995
Akira Otaka; Kengo Miyoshi; Peter P. Roller; Terrence R. Burke; Hirokazu Tamamura; Nobutaka Fujii
A practical synthesis of phosphopeptides was achieved using a combination of dimethyl-protected phosphoamino acids and two-step deprotection protocols consisting of high acidic (SN1/SN2) and low acidic (SN2) reagent systems.
Bioorganic & Medicinal Chemistry Letters | 2001
Terrence R. Burke; Zhu-Jun Yao; Bin Ye; Kengo Miyoshi; Akira Otaka; Li Wu; Zhong Yin Zhang
Azatyrosine (AzaTyr, 4) is a natural product isolated from Streptomyces chibanesis, whose structure is characterized by a nitrogen atom in the aryl ring of a tyrosyl residue. This seemingly minor modification to the tyrosyl residue results in profound physiological effects, as AzaTyr has been shown to promote permanent reversion of ras-dependent transformed cells to the normal phenotype in culture and to inhibit chemical induction of carcinogenesis in transgenic mice bearing oncogenic human ras. The mechanisms underlying these effects are not known, however ras-pathways involve an intricate balance between both protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs). The present study was undertaken to examine the general utility of AzaTyr as a structural motif for PTP inhibitor design by examining the phospho-azatyrosine (pAzaTyr)-containing peptide Ac-Asp-Ala-Asp-Glu-pAzaTyr-Leu-amide (8) in a PTP1 enzyme system. Kinetic analysis indicated that 8 binds with a Km value of 210 microM and a catalytic turnover rate, kcat of 52 s(-1). This represents a greater than 50-fold reduction in binding affinity relative to the parent phosphotyrosine-containing peptide, indicating that the aryl nitrogen adversely affects binding affinity. The much lower PTP affinity of the pAzaTyr-containing peptide reduces the potential utility of the AzaTyr pharmacophore for PTP inhibitor design. These results are discussed from the point of view that incorporation of AzaTyr residues into proteins could result in perturbation of protein-tyrosine phosphorylation,dephosphorylation cascades that control signal transduction processes, including ras-dependent pathways.
Archive | 1999
Kengo Miyoshi; Akira Otaka; Midori Kaneko; Hirokazu Tamamura; Nobutaka Fujii
Protein phosphorylation provides structural and functional changes for proteins involved in intracellular signal transduction pathways [1]. Due to the important role of phosphorylation/dephosphorylation in biology, long chain phosphopeptides have received much attention as useful biological and biochemical tools to elucidate various cellular processes including signal transduction. Previously we reported a efficient synthetic methodology for phosphopeptides [2, 3]. In the present study, we tried to develop a new synthetic methodology for long chain phosphopeptides and found that partially protected phosphopeptide fragments [ClZ(2-chlorobenzyloxycarbonyl) group for lysine and methyl groups for phosphoamino acids] can be obtained by treatment of protected peptidyl resins with High TFMSA system with efficient cleavage and removal of the other protecting groups. This finding prompted us to apply the High TFMSA system to the preparations of the useful partially protected phosphopeptide fragments as the building blocks in thioester fragment condensation strategy [4]. Here, we report the convenient synthetic method of phosphopeptide fragments using High TFMSA system.
Archives of Biochemistry and Biophysics | 2000
Motoyoshi Nomizu; Yuichiro Kuratomi; M. Lourdes Ponce; Sang-Yong Song; Kengo Miyoshi; Akira Otaka; Sharon K. Powell; Matthew P. Hoffman; Hynda K. Kleinman; Yoshihiko Yamada
Journal of Organic Chemistry | 1995
Akira Otaka; Kengo Miyoshi; Midori Kaneko; Hirokazu Tamamura; Nobutaka Fujii; Motoyoshi Nomizu; Terrence R. Burke; Peter P. Roller
Chemical & Pharmaceutical Bulletin | 2000
Kengo Miyoshi; Akira Otaka; Midori Kaneko; Hirokazu Tamamura; Nobutaka Fujii
Synlett | 1998
Zhu-Jun Yao; Bin Ye; Kengo Miyoshi; Akira Otaka; Terrence R. Burke
Peptide science : proceedings of the ... Japanese Peptide Symposium | 1998
Akira Otaka; Etsuko Mitsuyama; Kengo Miyoshi; Nobutaka Fujii